ABSCI CORPORATION - COMMON STOCK
3.7000
27-January-25 14:02:10
15 minutes delayed
Stocks
-0.3000
-7.50%
Today's range
3.6700 - 4.1981
ISIN
N/A
Source
NASDAQ
-
Absci to Participate in Upcoming Investor Conferences
28 Aug 2023 16:05:00 By Nasdaq GlobeNewswire
-
Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results
14 Aug 2023 08:02:00 By Nasdaq GlobeNewswire
-
Absci Appoints Zach Jonasson, Ph.D., as Chief Financial Officer and Chief Business Officer
14 Aug 2023 08:00:00 By Nasdaq GlobeNewswire
-
10 Aug 2023 08:00:00 By Nasdaq GlobeNewswire
-
Absci to Participate in the UBS MedTech, Tools and Genomics Summit 2023
01 Aug 2023 08:00:01 By Nasdaq GlobeNewswire
-
Absci to Participate in the Canaccord Genuity 43rd Annual Growth Conference
26 Jul 2023 08:00:00 By Nasdaq GlobeNewswire
-
Absci to Participate in the Morgan Stanley 2nd Annual Biotechnology AI Summit
15 Jun 2023 08:00:00 By Nasdaq GlobeNewswire
-
06 Jun 2023 08:00:02 By Nasdaq GlobeNewswire
-
Absci Reports Business Updates and First Quarter 2023 Financial and Operating Results
15 May 2023 16:05:00 By Nasdaq GlobeNewswire
-
11 May 2023 08:00:01 By Nasdaq GlobeNewswire
-
Absci to Participate in the 22nd Annual Needham Virtual Healthcare Conference
06 Apr 2023 08:00:00 By Nasdaq GlobeNewswire
-
Absci Partners with Bioinformatics Company M2GEN to Accelerate Drug Creation for Oncology
04 Apr 2023 08:00:00 By Nasdaq GlobeNewswire
-
Absci Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
30 Mar 2023 16:05:00 By Nasdaq GlobeNewswire
-
23 Mar 2023 08:00:00 By Nasdaq GlobeNewswire
-
Absci to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
07 Mar 2023 08:00:01 By Nasdaq GlobeNewswire
-
28 Feb 2023 08:00:01 By Nasdaq GlobeNewswire
-
Absci to Participate in the 43rd Annual Cowen Health Care Conference
21 Feb 2023 08:00:02 By Nasdaq GlobeNewswire
-
St. John’s Cancer Institute Partners with Absci to Expedite Development of Cancer Therapies
09 Feb 2023 08:00:01 By Nasdaq GlobeNewswire
-
Absci Deepens Scientific Advisory Board to Accelerate Generative AI Drug Creation
08 Feb 2023 08:00:00 By Nasdaq GlobeNewswire
-
Absci First to Create and Validate De Novo Antibodies with Zero-Shot Generative AI
10 Jan 2023 08:00:02 By Nasdaq GlobeNewswire